Phase IV, safety and pharmacokinetics of probucol and cilostazol when coadministered in healthy subjects

Trial Profile

Phase IV, safety and pharmacokinetics of probucol and cilostazol when coadministered in healthy subjects

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Cilostazol (Primary) ; Probucol (Primary)
  • Indications Arterial occlusive disorders; Embolism and thrombosis; Intermittent claudication; Stroke
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Korea Otsuka Pharmaceutical
  • Most Recent Events

    • 21 Oct 2009 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
    • 21 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 13 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top